Rhumbline Advisers Gelesis Holdings, Inc. Transaction History

Rhumbline Advisers

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$0.11 - $0.52 $12 - $57	110 Added 0.69%	15,984 $3,000
Q4 2022 Feb 14, 2023	SELL	$0.22 - $0.51 $371 - $861	-1,690 Reduced 9.62%	15,874 $5,000
Q3 2022 Nov 10, 2022	BUY	$0.08 - $1.34 $110 - $1,843	1,376 Added 8.5%	17,564 $19,000
Q2 2022 Aug 11, 2022	BUY	N/A	16,188 New	16,188 $25,000

4.7K

Ticker GLS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,946,704
Market Cap $1.46M
Description
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.